使用硼替佐米成功治疗ABO血型不匹配的异基因造血细胞移植后同种血凝素介导的纯红细胞再生障碍。 - Suppr

Suppr

超能文献

Successful treatment of isohemagglutinin-mediated pure red cell aplasia after ABO-mismatched allogeneic hematopoietic cell transplant using bortezomib.

作者信息

Poon L-M, Koh L P

出版信息

Bone Marrow Transplant. 2012 Jun;47(6):870-1. doi: 10.1038/bmt.2011.176. Epub 2011 Aug 29.

DOI:10.1038/bmt.2011.176

PMID:21874058

Abstract

摘要

相似文献

Successful treatment of isohemagglutinin-mediated pure red cell aplasia after ABO-mismatched allogeneic hematopoietic cell transplant using bortezomib.使用硼替佐米成功治疗ABO血型不匹配的异基因造血细胞移植后同种血凝素介导的纯红细胞再生障碍。

Bone Marrow Transplant. 2012 Jun;47(6):870-1. doi: 10.1038/bmt.2011.176. Epub 2011 Aug 29.

Rituximab for pure red cell aplasia after ABO-mismatched allogeneic peripheral blood progenitor cell transplantation.利妥昔单抗治疗ABO血型不合的异基因外周血祖细胞移植后纯红细胞再生障碍性贫血

Transfusion. 2005 Apr;45(4):643-5. doi: 10.1111/j.0041-1132.2005.00445.x.

[Pure red cell aplasia after allogeneic transplantation of ABO incompatible hematopoietic stem cells].[ABO血型不合造血干细胞异体移植后纯红细胞再生障碍性贫血]

Medicina (B Aires). 2002;62(6):575-7.

Successful treatment of pure red cell aplasia with repeated, low doses of rituximab in two patients after ABO-incompatible allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia.两名急性髓系白血病患者在接受ABO血型不相合的异基因造血干细胞移植后，通过重复给予低剂量利妥昔单抗成功治疗纯红细胞再生障碍性贫血。

Haematologica. 2005 Nov;90 Suppl:ECR33.

Subcutaneous bortezomib is highly effective for pure red cell aplasia after ABO-incompatible haematopoietic stem cell transplantation.皮下注射硼替佐米对ABO血型不合造血干细胞移植后纯红细胞再生障碍性贫血高度有效。

Transfus Med. 2014 Jun;24(3):187-8. doi: 10.1111/tme.12121. Epub 2014 May 9.

Successful treatment of pure red cell aplasia with a single low dose of rituximab in two patients after major ABO incompatible peripheral blood allogeneic stem cell transplantation.两例主要ABO血型不合外周血异基因干细胞移植后患者单次低剂量利妥昔单抗成功治疗纯红细胞再生障碍性贫血。

Transfus Med. 2012 Aug;22(4):302-4. doi: 10.1111/j.1365-3148.2012.01156.x. Epub 2012 Apr 30.

Pure red cell aplasia after allogeneic stem cell transplantation with reduced conditioning.减低预处理的异基因干细胞移植后纯红细胞再生障碍

Bone Marrow Transplant. 2000 Oct;26(8):911-5. doi: 10.1038/sj.bmt.1702629.

Pure red-cell aplasia following major and bi-directional ABO-incompatible allogeneic stem-cell transplantation: recovery of donor-derived erythropoiesis after long-term treatment using different therapeutic strategies.主要和双向ABO血型不相合的异基因干细胞移植后发生的纯红细胞再生障碍：采用不同治疗策略长期治疗后供体来源红细胞生成的恢复

Ann Hematol. 2007 Sep;86(9):677-83. doi: 10.1007/s00277-007-0304-8. Epub 2007 May 8.

Pure Red Cell Aplasia following ABO-Mismatched Allogeneic Hematopoietic Stem Cell Transplantation: Resolution with Daratumumab Treatment.ABO 血型不合异基因造血干细胞移植后纯红细胞再生障碍：达妥木单抗治疗后缓解。

Acta Haematol. 2021;144(6):683-687. doi: 10.1159/000515257. Epub 2021 Apr 22.

Successful treatment of pure red cell aplasia because of ABO major mismatched stem cell transplant.ABO主要错配干细胞移植所致纯红细胞再生障碍性贫血的成功治疗

J Clin Apher. 2018 Feb;33(1):108-112. doi: 10.1002/jca.21553. Epub 2017 May 24.

引用本文的文献

Treatment-free survival to bortezomib combined with dexamethasone in patients with refractory/relapsed pure red cell aplasia: a prospective clinical study.硼替佐米联合地塞米松治疗难治性/复发性纯红细胞再生障碍性贫血患者的无治疗生存期：一项前瞻性临床研究。

Ann Med. 2025 Dec;57(1):2540016. doi: 10.1080/07853890.2025.2540016. Epub 2025 Aug 7.

Seven-years post allogeneic hematopoietic stem cell transplantation pure red cell aplastic anemia cured with daratumumab: A case report and review of literature.异基因造血干细胞移植七年后，达雷妥尤单抗治愈纯红细胞再生障碍性贫血：一例报告并文献复习

World J Clin Cases. 2024 Aug 26;12(24):5604-5612. doi: 10.12998/wjcc.v12.i24.5604.

Daratumumab as a Frontline Immunosuppression for Pure Red Cell Aplasia after Major ABO-mismatched Allogeneic Hematopoietic Stem Cell Transplantation.达雷妥尤单抗作为主要ABO血型不合的异基因造血干细胞移植后纯红细胞再生障碍的一线免疫抑制治疗。

Leuk Res Rep. 2022 Apr 13;17:100314. doi: 10.1016/j.lrr.2022.100314. eCollection 2022.

Post-hematopoietic stem cell transplantation immune-mediated anemia: a literature review and novel therapeutics.造血干细胞移植后免疫介导性贫血：文献回顾与新型治疗方法。

Blood Adv. 2022 Apr 26;6(8):2707-2721. doi: 10.1182/bloodadvances.2021006279.

Pure red cell aplasia after major or bidirectional ABO incompatible hematopoietic stem cell transplantation: to treat or not to treat, that is the question.主要或双向 ABO 不相容造血干细胞移植后纯红细胞再生障碍：治疗还是不治疗，这是个问题。

Bone Marrow Transplant. 2021 Apr;56(4):769-778. doi: 10.1038/s41409-020-01124-6. Epub 2020 Nov 14.

Successful treatment of thrombocytopenia with daratumumab after allogeneic transplant: a case report and literature review.异基因移植后使用达雷妥尤单抗成功治疗血小板减少症：一例病例报告及文献综述

Blood Adv. 2020 Mar 10;4(5):815-818. doi: 10.1182/bloodadvances.2019001215.

Management of refractory autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation: current perspectives.异基因造血干细胞移植后难治性自身免疫性溶血性贫血的管理：当前观点

J Blood Med. 2019 Aug 8;10:265-278. doi: 10.2147/JBM.S190327. eCollection 2019.

Successful treatment of severe immune hemolytic anemia after allogeneic stem cell transplantation with bortezomib: report of a case and review of literature.硼替佐米成功治疗异基因干细胞移植后的严重免疫性溶血性贫血：1例报告并文献复习

Transfusion. 2015 Feb;55(2):259-64. doi: 10.1111/trf.12815. Epub 2014 Aug 25.

Transfus Med. 2014 Jun;24(3):187-8. doi: 10.1111/tme.12121. Epub 2014 May 9.

Incidence and natural history of pure red cell aplasia in major ABO-mismatched haematopoietic cell transplantation.主要 ABO 不相合造血细胞移植中纯红细胞再生障碍的发生率和自然病程。

Br J Haematol. 2013 Mar;160(6):798-805. doi: 10.1111/bjh.12210. Epub 2013 Jan 18.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验